Drug intelligence / Profile preview

Metsyn X

Development stage
Unknown
Lead developer
Delfran Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Metsyn X (also known as MetsynX) is a nutraceutical supplement developed and distributed by Delfran Pharmaceuticals, a South African company specializing in female healthcare. The product is a combination of myo-inositol and d-chiro-inositol in a physiological 40:1 ratio, designed to support glucose metabolism and address insulin resistance. Mechanistically, these inositols serve as precursors to inositol phosphoglycans, which act as secondary messengers in the insulin signaling pathway; myo-inositol facilitates glucose uptake and cellular response, while d-chiro-inositol promotes glycogen synthesis. Metsyn X is indicated for individuals with metabolic syndrome (Syndrome X), central obesity, and other conditions linked to disrupted insulin sensitivity. It is administered orally as a powder sachet dissolved in water.

Brand names
Metsyn XMETSYN X™MetsynX
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on Metsyn X.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metsyn X.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call